Wall Street Experts

Prognozy kwartalne Ascendis Pharma A/S

2021-012022-012023-012024-012025-012026-012027-010100M200M300M400M500M
Prognozy przychodówPrzychody

Dane w mln

3 12 2 11 10 1 9 0
Okres 2024-12-31 2024-12-31 2025-03-31 2025-03-31 2025-06-30 2025-06-30 2025-09-30 2025-09-30 2025-12-31 2025-12-31 2026-03-31 2026-03-31 2026-06-30 2026-06-30 2026-09-30 2026-09-30 2026-12-31 2026-12-31
Przychód (średnia) 119.66 119.66 94.81 94.81 145.81 145.81 198.77 198.77 244.81 244.81 274.39 274.39 348.86 348.86 406.41 406.41 486.34 486.34
Przychód Δ kw/kw -75.40% 0.00% -20.77% -20.77% 53.80% 53.80% 36.32% 36.32% 23.16% 23.16% 12.08% 12.08% 27.14% 27.14% 16.50% 16.50% 19.67% 19.67%
Przychód (min) 75.84 75.84 79.66 79.66 116.58 116.58 158.92 158.92 195.74 195.74 219.39 219.39 278.93 278.93 324.94 324.94 388.85 388.85
Przychód (max) 186.05 186.05 105.74 105.74 166.97 166.97 227.62 227.62 280.34 280.34 314.22 314.22 399.49 399.49 465.40 465.40 556.92 556.92
EBITDA (średnia) -114.82 -114.82 -90.97 -90.97 -139.91 -139.91 -190.72 -190.72 -234.90 -234.90 -263.28 -263.28 -334.73 -334.73 -389.96 -389.96 -466.65 -466.65
EBIT (średnia) -115.98 -115.98 -91.89 -91.89 -141.33 -141.33 -192.66 -192.66 -237.28 -237.28 -265.95 -265.95 -338.13 -338.13 -393.92 -393.92 -471.38 -471.38
EBIT % -96.93% -96.93% -96.93% -96.93% -96.93% -96.93% -96.93% -96.93% -96.93% -96.93% -96.93% -96.93% -96.93% -96.93% -96.93% -96.93% -96.93% -96.93%
Zysk netto (średni) -59.07 -59.07 -88.02 -88.02 -87.27 -87.27 -49.71 -49.71 -27.07 -27.07 12.48 12.48 -19.34 -19.34 120.09 120.09 153.38 153.38
Zysk netto % -49.36% -49.36% -92.84% -92.84% -59.85% -59.85% -25.01% -25.01% -11.06% -11.06% 4.55% 4.55% -5.54% -5.54% 29.55% 29.55% 31.54% 31.54%
EPS (średnia)
Liczba analityków (Przychody) 9 9 5 5 13 13 10 10 5 5 6 6 6 6 6 6 6 6
Liczba analityków (EPS) 10 10 5 5 11 11 7 7 5 5 4 4 4 4 7 7 4 4
symbol ASND ASND ASND ASND ASND ASND ASND ASND ASND ASND ASND ASND ASND ASND ASND ASND ASND ASND